Mytide has digitized the production of synthetic peptides and proteins. Our technology is 30x faster and provides access to trillions of new molecules.
Stage
Product In Market
Industry
Biotechnology
Location
Boston, MA, USA
Currency
USD
Founded
June 2018
Employees
10
Incorporation Type
C-corp
Company Summary
Mytide is focused on the digitization of peptide-based scaffolds by leveraging robotics, machine learning, and continuous manufacturing. Our platform allows us to make them 30x faster, directly scalable, and with a 4x lower production cost. Peptides represent one of the most promising next-generation treatments in oncology, infectious, and autoimmune disease areas. .